Kenneth Gordon to ROC Curve
This is a "connection" page, showing publications Kenneth Gordon has written about ROC Curve.
Connection Strength
0.220
-
Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis. J Dermatolog Treat. 2017 02; 28(1):3-7.
Score: 0.120
-
Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis. Br J Dermatol. 2013 Dec; 169(6):1337-41.
Score: 0.100